- Presentations
- 6
- Markets
- 1
Ibrance is a brand of Palbociclib marketed by Pfizer Laboratories, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Palbociclib
- Brand owner
- Pfizer Laboratories
- Registered in
- United States
- Strengths and forms
- 100 mg capsule, 125 mg capsule, 75 mg capsule, 100 mg tablet, 125 mg tablet, 75 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ibrance 100 mg capsuleOral | Pfizer Laboratories | US FDA | Available on request |
| Ibrance 125 mg capsuleOral | Pfizer Laboratories | US FDA | Available on request |
| Ibrance 75 mg capsuleOral | Pfizer Laboratories | US FDA | Available on request |
| Ibrance 100 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Ibrance 125 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
| Ibrance 75 mg tabletOral | Pfizer Laboratories | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ibrance
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.